rs765914103

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2

The NM_004586.3(RPS6KA3):​c.1237A>G​(p.Arg413Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000415 in 1,204,755 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000037 ( 0 hom. 2 hem. )

Consequence

RPS6KA3
NM_004586.3 missense

Scores

1
2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 1.80

Publications

0 publications found
Variant links:
Genes affected
RPS6KA3 (HGNC:10432): (ribosomal protein S6 kinase A3) This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS). [provided by RefSeq, Jul 2008]
RPS6KA3 Gene-Disease associations (from GenCC):
  • Coffin-Lowry syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, ClinGen, G2P
  • intellectual disability, X-linked 19
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • symptomatic form of Coffin-Lowry syndrome in female carriers
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 36 curated pathogenic missense variants (we use a threshold of 10). The gene has 11 curated benign missense variants. Gene score misZ: 4.5208 (above the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to symptomatic form of Coffin-Lowry syndrome in female carriers, Coffin-Lowry syndrome, non-syndromic X-linked intellectual disability, intellectual disability, X-linked 19.
BP4
Computational evidence support a benign effect (MetaRNN=0.193367).
BS2
High Hemizygotes in GnomAdExome4 at 2 AD,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RPS6KA3NM_004586.3 linkc.1237A>G p.Arg413Gly missense_variant Exon 15 of 22 ENST00000379565.9 NP_004577.1 P51812A0A384MDW3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RPS6KA3ENST00000379565.9 linkc.1237A>G p.Arg413Gly missense_variant Exon 15 of 22 1 NM_004586.3 ENSP00000368884.3 P51812

Frequencies

GnomAD3 genomes
AF:
0.00000888
AC:
1
AN:
112589
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
182390
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000366
AC:
4
AN:
1092166
Hom.:
0
Cov.:
27
AF XY:
0.00000559
AC XY:
2
AN XY:
358072
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26264
American (AMR)
AF:
0.00
AC:
0
AN:
35153
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19309
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30076
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53878
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4059
European-Non Finnish (NFE)
AF:
0.00000478
AC:
4
AN:
837040
Other (OTH)
AF:
0.00
AC:
0
AN:
45895
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000888
AC:
1
AN:
112589
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34739
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31037
American (AMR)
AF:
0.00
AC:
0
AN:
10631
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3626
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2759
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6155
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53291
Other (OTH)
AF:
0.00
AC:
0
AN:
1515
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 21, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 07, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Coffin-Lowry syndrome;C0796225:Intellectual disability, X-linked 19 Uncertain:1
Nov 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
22
DANN
Benign
0.82
DEOGEN2
Benign
0.12
T;T;.;.;.;.;.;.;.;.;.;T
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.87
.;D;.;.;.;.;.;D;.;.;D;D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.075
N;N;.;.;.;.;.;.;.;.;.;.
PhyloP100
1.8
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
2.0
N;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
0.096
Sift
Benign
0.46
T;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
0.49
T;.;.;.;.;.;.;.;.;.;.;.
Polyphen
0.0
B;B;B;B;B;B;B;.;B;B;B;B
Vest4
0.27
MutPred
0.44
Gain of catalytic residue at F418 (P = 0.1114);Gain of catalytic residue at F418 (P = 0.1114);.;.;.;.;.;.;.;.;.;.;
MVP
0.54
MPC
1.8
ClinPred
0.67
D
GERP RS
5.1
PromoterAI
-0.0022
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.72
gMVP
0.82
Mutation Taster
=2/98
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs765914103; hg19: chrX-20190980; API